Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 26, 2022; 10(30): 11049-11058
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.11049
Figure 1
Figure 1 Pituitary magnetic resonance imaging and laboratory examination results in case 1. A: The pituitary was normal before starting immunotherapy (November 30, 2019); B: Pituitary enlargement was not found at the onset of immune-related hypophysitis (July 26, 2020); C: The pituitary was normal after steroid treatment (December 18, 2020); D: The levels of adrenocorticotropic hormone and cortisol; E: The levels of thyroid stimulating hormone and free thyroxine. ACTH: Adrenocorticotropic hormone; TSH: Thyroid stimulating hormone; FT4: Free thyroxine.